1Mornex F, Giraud P, Van Houtte P, et al. Conformal radiotherapy of non-small-cell lung cancer[J]. Cancer Radiother,1999,3(5):425-436.
2Giraud P, Jaulerry C, Brunin F, et al. Upper aerodigestive tract cancers: clinical benefits of conformal radiotherapy and intensity modulation[J].Cancer Radiother,2002,6(Suppl 1):37s-48s.
3Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma[J]. Int J Radiat Oncol Biol Phys,2002,52 (1): 49-57.
4Werner-Wasik M, Xiao Y, Pequignot E, et al. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study[J]. Int J Radiat Oncol Biol Phys,2001,51(1):56-61.
5Willner J, Baier K, Caragiani E, et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys,2002,52(2):382-389.
6Hayakawa K, Mitsuhashi N, Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer [J].Lung Cancer,1999,26(3):137-142.
8Robertson JM, Ten Haken RK, Hazuka MB, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy[J]. Int J Radiat Oncol Biol Phys,1997,37(5):1079-1085.
9Sibley GS, Mundt AJ, Shapiro C, et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy[J]. Int J Radiat Oncol Biol Phys,1995,33(5):1001-1007.
10Armstrong J, Raben A, Zelefsky M, et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer[J]. Radiother Oncol,1997,44(1):17-22.
2Villomueva AG, Lo TC, Beamis JF, et al. Endobronchial brachytherapy[J]. Clin Chest Med, 1995,16(3): 445-454.
3Langendijk H, De Jong J, T jwa M, et al. External irradiation versua external irradiation plus endobronchial brachytherapy in inoperable nonsomall cell lung cancer: a prospective study[J].Radiother oncol, 2001,58 (3): 257-268.
4Taulelle M,Chauvet B, Vincent P, et al. High-olose-rate endobrochial brachytherapy: results and complications in 189 patients[J]. Enr Respir J, 1998,11 ( 1 ): 162-168.
5Muto P,Ravo V,Panelli G,et al. High-dose-rate brachytherapy of bronchial cancer: treatment optimigation using three schemes of t herapy[J ]. Oncikigistm, 2000,5 ( 3 ): 209-214.
6Senan S, Burgers S, Samson M J, et al. Can elective nodal irradiation be omitted in stage Ⅲ non-small-cell lung cancer? Analysis of recurrences in a phase Ⅱ study of induction chemotherapy and involved-field radiotherapy [J]. Int J Radiat Oncol Biol Phys,2002,54(4) :999- 1006.
7Tsujino K, Hirota S, Obayashi K, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer [J]. Int J Radiat Oncol Biol Phys,2003,55(1) :110-115.
8Fu X L, Huang H, Bentel G ,et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta [J]. Int J Radiat Oncol Biol Phys, 2001, 50(4):899-908.
